A detailed history of Bank Of Montreal transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Bank Of Montreal holds 668,747 shares of ALXO stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
668,747
Previous 682,394 2.0%
Holding current value
$1.1 Million
Previous $423,000 33.81%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025

SELL
$0.41 - $0.61 $5,595 - $8,324
-13,647 Reduced 2.0%
668,747 $280,000
Q1 2025

May 13, 2025

SELL
$0.62 - $1.86 $89,396 - $268,189
-144,188 Reduced 17.44%
682,394 $423,000
Q4 2024

Feb 13, 2025

BUY
$1.21 - $1.87 $1 Million - $1.55 Million
826,582 New
826,582 $1.38 Million

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $66.8M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.